Podcast appearances and mentions of Sam Clark

Dr. Sam Clark, Founder and CEO of Terran Biosciences, is developing a long-acting once-daily formulation of a new class of antipsychotic drugs to treat schizophrenia. The use of a prodrug approach to modify the new drug Cobenfy allows for improved bioavailability and has been shown to have fewer side effects than traditional antipsychotics. This novel class of antipsychotic drugs targets the muscarinic receptor system, which is a different mechanism of action compared to existing treatments.  Sam explains, "Schizophrenia is a very severe disease. It has both hallucinations and delusions. It also has a set of symptoms called negative symptoms, which encompass social withdrawal and symptoms that can resemble depressive symptoms, cognitive dysfunction, and memory issues. So, with this patient population, there are a number of drugs that are approved to treat schizophrenia called antipsychotics. But until now, there hasn't been a new drug approved with a new mechanism. So, all drugs have the same mechanism to treat the disease since the 1950s."  "But we just got, right now in the space, a new drug approved from Bristol Myers. It just got approved, and Cobenfy is the first new mechanism to treat schizophrenia since the 1950s. But there are some downsides to that drug in that it's dosed twice daily as an oral drug, and there's currently no long-acting injectable. And so, twice daily can be difficult for patients with schizophrenia to take. The space is moving towards long-acting injectables, which can last just one injection for several months." "Now, that strategy has been used with other anti-psychotics on the market, such as Invega, to improve their bioavailability and make long-acting forms. So we took that same approach and created the long-acting prodrugs of Cobenfy, which are TerXT, those long-acting prodrugs. We believe that that will enable a once-daily form and a long-acting injectable that can go multiple months from a single injection and thus improve options for patients with schizophrenia."  #TerranBio #Prodrug #Antipsychotic #Schizophrenia #MentalHealth terranbiosciences.com Download the transcript here

Dr. Sam Clark, Founder and CEO of Terran Biosciences, is developing a long-acting once-daily formulation of a new class of antipsychotic drugs to treat schizophrenia. The use of a prodrug approach to modify the new drug Cobenfy allows for improved bioavailability and has been shown to have fewer side effects than traditional antipsychotics. This novel class of antipsychotic drugs targets the muscarinic receptor system, which is a different mechanism of action compared to existing treatments.  Sam explains, "Schizophrenia is a very severe disease. It has both hallucinations and delusions. It also has a set of symptoms called negative symptoms, which encompass social withdrawal and symptoms that can resemble depressive symptoms, cognitive dysfunction, and memory issues. So, with this patient population, there are a number of drugs that are approved to treat schizophrenia called antipsychotics. But until now, there hasn't been a new drug approved with a new mechanism. So, all drugs have the same mechanism to treat the disease since the 1950s."  "But we just got, right now in the space, a new drug approved from Bristol Myers. It just got approved, and Cobenfy is the first new mechanism to treat schizophrenia since the 1950s. But there are some downsides to that drug in that it's dosed twice daily as an oral drug, and there's currently no long-acting injectable. And so, twice daily can be difficult for patients with schizophrenia to take. The space is moving towards long-acting injectables, which can last just one injection for several months." "Now, that strategy has been used with other anti-psychotics on the market, such as Invega, to improve their bioavailability and make long-acting forms. So we took that same approach and created the long-acting prodrugs of Cobenfy, which are TerXT, those long-acting prodrugs. We believe that that will enable a once-daily form and a long-acting injectable that can go multiple months from a single injection and thus improve options for patients with schizophrenia."  #TerranBio #Prodrug #Antipsychotic #Schizophrenia #MentalHealth terranbiosciences.com Listen to the podcast here

March 20, 2025 ~ Dr. Robert Livernois fills in for Kevin as he honors his sponsors of School Talks. Gary Collins, principal attorney at Collins and Blaha, P.C. and Sam Clark, CEO of Clark Construction, joins Dr. Livernois as sponsors of the show.

Welcome to Episode 176 of The Darlington Podcast! In this episode, Content Manager Maddie Chastain talks with varsity coaches Sam Clark (volleyball), Brant Evans (boys' and girls' cross country), Betina Fuentes (football cheerleading), Wayne Groves (football), Anna Harris (softball) and Melissa Smyly (competition cheerleading) about the fall athletic season at Darlington. You'll hear a little bit about each team and their highlights of the spring season, from the pre-season to team bonding to their accomplishments and more. Click here for complete show notes >>

Sam Clark, founder and CEO of Terran Biosciences, shares his insights with BioBoss host John Simboli about leadership in biopharma and how Terran is working to develop therapeutics and technologies for patients with neurological and psychiatric diseases. 

Read the article at comedywham.com Episode #336 [VIDEO EPISODE] Sam Clark talks with Valerie Lopez about: His debut special, Built for Math How his accidental presidency of Harvard Student council How aforementioned presidency became the inspiration for his debut film, Fairview Dad Recorded October 2024 Follow Sam Website - https://www.theonlysamclark.com/ Instagram - https://www.instagram.com/theonlysamclark/ TikTok - https://www.tiktok.com/@theonlysamclark Youtube - https://www.youtube.com/@samtkd777 Facebook - https://www.facebook.com/sam.clark.5895/ Vimeo - https://vimeo.com/user54525094 Sam can be seen and heard: Built for Math - Debut Special (watch here) Amazon's Laugh After Dark - watch samclarkforcitycouncil.com Fairview - Debut film, winner of 19 awards across 32 film festivals. Learn more at Full film release coming soon!!! Stay tuned! Hershel and the Hanukkah Goblins: An Unauthorized Parody Musical - Preview here Stay tuned for a return to New York stags in 2025! Hot Sets Comedy Show - check for upcoming shows here Follow @ComedyWham on Instagram, Facebook, Youtube, Twitch, and Tiktok   If you'd like to support our independent podcast, check out our Patreon page at: Patreon.com/comedywham  .    You can also support us on Venmo or Paypal - just search for ComedyWham.  

Join senior editor Andrea Corona and Sam Clark, CEO and founder of Terran Biosciences, for a discussion on KarXT's landmark approval, schizophrenia treatment barriers, prodrugs, and more.  Extended Release is an Off Script series that allows us to revisit conversations with our sources to explore new developments, gain deeper insights, and provide updates on the impact of their work. Each episode goes beyond the initial story, offering a richer understanding of key topics and ongoing innovations in the pharma industry.

On this week's Tech Nation, Moira speaks with Co-Founder and Co-CEO of NewsGuard, Steven Brill about his book, “The Death of Truth”  about the negative impact of the Internet and Social Media and what we can do about it. Then, what science tells us about the treatment potential of Hallucinogens without the hallucinations with, Dr. Sam Clark, CEO of Terran Biosciences. Also covered - Terran's extensive efforts to build prodrugs

Welcome to episode 052 of Life Sciences 360.In this episode, of Life Sciences as we dive into the fascinating world of psychedelic therapeutics with Dr. Sam Clark, the Chief Executive Officer of Terran Biosciences. Dr. Clark shares his journey of founding Terran Biosciences, motivated by the need for better treatment options for psychiatric and neurological disorders. Discover how Terran Biosciences is leveraging a tech company structure to accelerate drug development, utilizing AI in imaging, and pioneering innovative prodrugs. Learn about the company's groundbreaking work in developing psychedelics without hallucinations and their mission to make these therapies affordable and accessible to patients. Subscribe for more insightful conversations with leaders in the biotech and life sciences industries!Chapters:00:00 - Introduction00:12 - Dr. Sam Clark's Motivation and Background01:00 - Founding Terran Biosciences01:35 - Challenges in Psychiatric and Neurological Treatment Development02:55 - Innovating with a Tech Company Structure03:18 - Use of AI and Drug Development Strategies04:18 - Slow Translation of Research to Therapies05:50 - Development of New Prodrugs07:12 - Explanation of Prodrugs08:49 - Terran's Lead Assets for Psychotic Disorders10:16 - Creating Long-Acting Prodrugs12:16 - Addressing Regulatory Hurdles in Psychedelic Research14:20 - Pipeline Overview and Future Plans16:13 - Importance of Collaboration in Psychedelic Research17:58 - The Rise of Big Pharma Interest in Neuroscience20:14 - Addressing Stigma Around Psychedelics23:02 - Overcoming Regulatory Challenges26:31 - Trends in Psychedelic Funding31:48 - Making Medications More Accessible37:00 - Impact of Psychedelic Approvals on the Industry38:20 - Focus on Patient-Centric Approaches41:11 - Final Thoughts and Future AnnouncementsFollow Terran Biosciences on LinkedIn and X, and visit their website for the latest updates and announcements. -----Links:- [Terran Biosciences on LinkedIn](https://www.linkedin.com/company/terran/)- [Terran Biosciences on X](https://x.com/terranbio)- [Dr. Sam Clark on X](https://x.com/neonneurons)- [Terran Biosciences Website](https://terranbio.com)- [Tera XT Website](https://teraxt.com)For more, check out the podcast website - www.lifesciencespod.com

At BIO2024, I spoke Sam Clark, CEO and founder of Terran Biosciences, about their development of new long-duration dosage forms for the treatment of schizophrenia . We discussed the development of prodrugs, the potential of psychedelics, and the journey of founding a biotech company. The Genesis of Terran BiosciencesSam's journey into biotech was personal. Growing up around friends and family members with severe mental illnesses like bipolar disorder and Alzheimer's disease, he saw the limitations of existing treatments. Through his studies at MIT and Columbia, he recognized the slow pace of development and the significant side effects of available medications. Existing treatments for mental illnesses have many unpleasant side effects from cause weight gain to Parkinsonian symptoms and hormonal disruptions. All of that led to his decision to found Terran Biosciences hoping to transform the standard of care.Terran's PipelineTerran's lead asset, TerXT, is a novel combination of prodrugs of xanomeline and trospium, compounds that have been around for a long time, but with less than ideal pharmacokinetics. They also have Idazoxan XR, an adjunctive treatment for schizophrenia, and several new forms of psychedelics like psilocybin and MDMA with differentiated pharmacokinetics aimed at making these treatments more accessible and affordable.Sam explained the significance of prodrugs in their approach. Unlike simple reformulations, prodrugs are entirely new compounds created by attaching a side chain to the original molecule. This attachment improves pharmacokinetics, allowing for more effective absorption and longer-lasting effects. For example, the older compounds xanomeline and trospium, which need to be taken twice daily, have been modified into prodrugs that can be administered once daily or as long-acting injectables with multi-month durations. This innovation not only simplifies the regimen for patients but also leverages the FDA's accelerated 505(b)(2) pathway, potentially bringing these new treatments to market faster.Overcoming Development ChallengesCreating effective prodrugs is no small task. Sam described the extensive process, involving a team of world experts and over 200 FTE chemists working tirelessly. They designed over 10,000 prodrugs, synthesized 700, and conducted 500 preclinical studies to refine their approach. This massive undertaking, though challenging, has led to promising results.Are you subscribed yet? If not, let's fix that.The Potential of PsychedelicsI also wanted to explore psychedelics, a field that has generated significant interest in recent years. Terran is developing new forms of MDMA, psilocybin, and 5-MeO-DMT, aiming to improve their pharmacokinetics and make these treatments more accessible. Sam highlighted MDMA's potential, currently under FDA review for treating PTSD, with a decision expected soon. (Right after we spoke, the FDA advisory panel recommended rejecting approval for MDMA. The decision has not been made yet.) By creating new forms and leveraging the 505(b)(2) pathway, Terran aims to overcome patent barriers and ensure these treatments are affordable.Insights into Brain FunctionI am particularly curious about anything we can learn about neurobiology from studies around these therapeutic compounds and psychedelics. Here is the challenge: Psychedelics, for example, act on multiple receptors. Teasing out different pathways in the brain is complicated. Functional MRI studies of people undergoing psychedelic trips show reproducible changes in brain pathways, suggesting potential mechanisms but the circuitry is complicated. There are no simple answers yet.The Journey of a First-Time FounderI asked Sam about his experience as a first-time founder. Terran's success is in large part due to its corporate structure, modeled after fast-moving Silicon Valley companies. By avoiding traditional hierarchical structures and instead utilizing a flat organization with world experts leading sub-teams, Terran has managed to solve complex problems efficiently.Team building has been essential to Terran's achievements. Sam's approach involves creating specialized teams for different facets of a problem, ensuring a comprehensive and collaborative effort. “Workflows” for the WinI have seen a pattern in several interviews recently. Changing a process can have as big of an effect on solving a problem (and creating success for a company) as developing a new product. In this case, it's a bit of both. The problem being solved by TerXT is the patient regimen. Prodrugs with longer-duration pharmacokinetics make adherence easier for the patient. At the same time, I appreciate the enormous amount of development effort that went into creating those prodrugs. A different approach to assembling teams and managing them is also a significant change in the workflow that will have an impact.Your deepest insights are your best branding. I'd love to help you share them. Chat with me about custom content for your life science brand. Or visit my website.If you appreciate this content, you likely know someone else who will appreciate it too. Please share it with them. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit cclifescience.substack.com

In this episode of Life Science Success, host Don interviews Dr. Sam Clark, founder and CEO of Terran Biosciences. They talk about Dr. Clark's innovative approach to creating new neuropsychiatric therapeutics and how his personal experiences with mental illness inspired him to enter the biotech industry.   The episode also explores various breakthroughs at Terran, including their innovative work with prodrugs, anti-psychotics, and psychedelics, along with their unique, efficient team structure modeled after Silicon Valley tech companies. Additionally, they delve into the inspiration, challenges, and methodologies that drive Terran's mission to provide affordable and modern treatments for patients in need.     00:00 Introduction to Life Science Success Podcast 00:40 Sponsor Message from D3 Digital Media Marketing 01:21 Guest Introduction: Dr. Sam Clark 02:12 Dr. Clark's Journey into Biotech 04:15 Founding Terran Biosciences 07:13 Innovative Projects at Terran 13:00 Psychedelic Compounds and Patient Use 20:00 Overcoming Barriers in Drug Development 23:57 Leadership and Inspiration 31:09 Conclusion and Final Thoughts

Esper's platform plays a crucial role in ensuring device security, compliance, and seamless updates, contributing to maintaining trial integrity and patient safety. In this episode, Sam Clark, Senior Director of Vendor Management and Procurement at Clinical Ink, and Sudhir Reddy, Esper's CTO, talk about the intersection of healthcare, technology, and device management. Sam discusses Clinical Ink's mission to improve clinical trials through technology and patient-centered research, highlighting the challenges of managing devices across 50 countries and multiple languages, emphasizing the need for tailored processes and secure solutions. Together, Sam and Sudhir explore the evolving role of devices in clinical trials, emphasizing Esper's platform's role in ensuring security, compliance, and updates for maintaining trial integrity and patient safety. They also underscore how the partnership between Clinical Ink and Esper reflects a commitment to innovation and problem-solving, with a vision for future automation and efficiency in clinical trial processes.  Tune in and learn how these collaborations are shaping the future of healthcare device management! Resources:  Find out more about the Esper thought leadership series here. Connect with and follow Sam Clark on LinkedIn. Connect with and follow Sudhir Reddy on LinkedIn and his blogs here. Discover more about Clinical Ink on their LinkedIn and website. Learn more about Esper on LinkedIn and their website.

This episode of the From Lab to Launch podcast, brought to you by Qualio, features Dr. Sam Clark, CEO of Terran Biosciences. With a background in neurosciences from MIT and an MD and PhD from Columbia University, Dr. Clark shares his journey from academia to leading a pioneering company in neuropsychiatric therapeutics. He discusses the challenges and innovations in the development and supply of GMP psychedelic compounds, highlighting how these substances are making significant strides toward transforming mental health treatment. Dr. Clark also explores Terran Biosciences' approach to overcoming drug development hurdles, emphasizing quality management and patent strategies to ensure the delivery of affordable, effective treatments. His insights offer a glimpse into the future of psychedelics in mainstream medicine and the broader implications for treating various disorders beyond mental health.https://terranbiosciences.com/ Dr. Sam Clark's LinkedIn: https://www.linkedin.com/in/sam-clark-md-phd-133139199/ 00:00 Welcome to From Lab to Launch!00:40 Introducing Dr. Sam Clark and Terran Biosciences01:23 Dr. Clark's Journey: From Academia to Neuropsychiatric Therapeutics02:48 The Renaissance of Psychedelic Therapeutics04:36 Challenges and Innovations in Drug Development08:36 Quality Management at Terran Biosciences10:23 The Future of Psychedelics in Mainstream Medicine12:46 Expanding Beyond Neuropsychiatry: Terran's Broader Impact14:02 Navigating Innovation and Ethics in Patenting17:48 Advice for Aspiring Scientists and Innovators20:42 Dr. Clark's Personal Inspirations and Closing Thoughts22:21 How to Follow Dr. Clark and Terran Biosciences23:00 Wrapping Up and How to Engage with From Lab to LaunchQualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez

Welcome to Episode 161 of The Darlington Podcast! In this episode, senior boarding student Mary Covington talks with varsity coaches Sam Clark (boys' lacrosse), Mallory Collier (girls' lacrosse), Betina Fuentes (boys' and girls' tennis), Kevin Hunt (boys' and girls' track and field), Matt Larry (baseball), Al Shorey (boys' and girls' soccer) and Jared Willerson (boys' and girls' golf) about the spring athletic season at Darlington. You'll hear a little bit about each team and their highlights of the spring season, from the pre-season to team bonding to their accomplishments and more. Click here for complete show notes >>

There is a clear demand for novel, neurological treatments. While it's widely known psychedelics hold enormous therapeutic potential, there are a host of challenges, including dosing and potential side effects for the patient.Our guest this week is Dr Sam Clark, who founded Terran Biosciences to develop a safe, effective portfolio of therapeutics and technologies for patients with neurological and psychiatric diseases. 00:52-04:09: About Terran Biosciences04:09-06:03: What are the challenges of using psychedelics?06:03-07:32: Is there still a stigma attached to use of psychedelics? 07:32-11:45: How do psychedelics work on the brain?11:45-13:44: Why are psychedelics a good treatment?13:44-16:51: What is Idazoxan XR?16:51-18:01: How do you make changes to drugs?18:01-21:19: How did you develop your business model?21:19-22:40: What are Eplivanserin and Volinanserin?22:40-24:49: How useful are repurposed drugs?24:49-29:06: Keeping drugs affordable29:06-30:31: Dealing with patents30:31-32:41: What are empathogens?32:41-33:12: Where is the company at with clinical trials?33:12-35:45: What is NM-101?35:45-37:47: How does Terran differ from other companies?37:47-39:54: Are you looking to cure conditions?39:54-40:48: SchizophreniaInterested in being a sponsor of an episode of our podcast? Discover how you can get involved here! Stay updated by subscribing to our newsletter

Have you ever considered the untapped potential of abandoned drugs? Join Dr. Sam Clark to discuss how his personal drive to combat mental illness is leading to breakthroughs in treatments for neurological and psychiatric diseases. Witness how Terran is not only resurrecting discarded medications for new purposes, but also pioneering the next generation of non-hallucinogenic psychedelic therapies aimed at tackling depression and Parkinson's psychosis. First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.

Věra Jourová is a Czech politician and lawyer who has been European Commissioner for Values and Transparency since 2019. She previously served as the EU's Justice Commissioner. More recently, she has added digital duties after the EU's digital commissioner Margethe Vestager took a leave of absence. Jourová is now responsible for the enforcement of the Digital Services Act, the EU's landmark content-moderation legislation. The tragic events unfolding in the Middle East and social-media platforms' role in spreading disinformation has been the first test for the DSA. Jourová is also focused on the AI Act, which is another initiative that has caught global attention. In an extended conversation with MLex reporters Matthew Newman and Sam Clark, Jourová goes over how she handles meetings with some of the biggest leaders of Silicon Valley to ensure they follow the EU's new rules.

Our guests Dr. Sam Clark, Associate Professor in Animal Genetics, and Dr. Peter McGilchrist, Associate Professor in Meat Science, will be sure to keep you on your toes  and give some interesting insights into the genetics and meat industries today! Plus, you know Sam's always got some toughies up his sleeve. The Breeder Exchange Podcast is produced by @breeder_genetics, an Australian bovine semen company. The podcast uncovers the story of sires within the Breeder Genetics program, and talks all things beef. Guests on the podcast include reputable individuals from successful programs globally. Follow us! Facebook: https://www.facebook.com/breederexchangeInstagram: https://www.instagram.com/breederexchange/

Dedicated to Southern Miss sports! Weekdays 1 - 2 p.m. on select SuperTalk Mississippi stations. This show is a production of SuperTalk Mississippi Media. Learn more at SuperTalk.FM

In this episode, Ryland Scott ('23) talks with varsity coaches Reid Owens (tennis), Justin Bruce (girls' golf), Jared Willerson (boys' golf), Kevin Hunt (track and field), Matt Larry (baseball), Mallory Collier (girls' lacrosse) and Sam Clark (boys' lacrosse) about the spring athletic season at Darlington. You'll hear a little bit about each team and their highlights of the spring season, from the preseason to team bonding to their accomplishments and more. Note: This episode was recorded on May 9. At the time of publication, the girls' tennis team went on to win the GHSA Single A Division I State Championship title, and Gus Gammage ('23) won a GHSA Single A Division I State Championship title in shot put. The baseball team made it to the Final Four round of the state playoffs, where they were eliminated by Prince Avenue Christian. Click here for complete show notes >>

If you only listen to one of my podcasts, please pick this one. Why? Because guest Sam Clark, CEO of Clark Construction in Lansing Michigan, candidly shares his organization's six year diversity, equity, and inclusion efforts and results in an authentic and meaningful way. Would you like for your organization to have a 99% engagement score? Or to grow from $200 million to $500 million in three years? Understanding "dominant culture" and learning how to build an inclusive organization has women and minorities beating down their doors and has significantly contributed to these business results. As Sam states, this isn't "white male bashing". It's understanding the barriers to success that people outside of the dominant culture face, addressing these barriers through inclusivity, and unleashing the tremendous innovation of diverse organizations.

An outdoor education camp turned into a rescue mission in Whangamatā for a couple of Papamoa College students.  15 years olds Ryan Teixeira and Sam Clark rescued a tourist who was barely above choppy water after being separated from his kayak.  Ryan Teixeira told Andrew Dickens he noticed the tourist while he was on a kayak trip himself.  "We instantly went oh no, we've got trouble on our hands," he said.  He says the man wasn't responded, so he jumped into the water to help.  "I had to chuck him on the kayak...we managed to get him on after a good 30 seconds of wrestling him on there."  LISTEN ABOVESee omnystudio.com/listener for privacy information.

A very special World Class Canada 10th Anniversary series, I will be bringing back the podcast for this special series. I will be interviewing the competitors on the first day of competition, through to the judges and finally the winner, Jacob Martin. Strap in and get ready for some old school Soole podcasting and we will have tons of fun along the way. Sam Clark went on to get a Top 4 spot at Nationals, and there is one thing I loved about this process this year was watching the competitors go from first day to final challenge. Share a dram with the hospitality industry's top global talents: bartenders, venue owners, distillers and industry aficionados. Shawn Soole has lived, breathed, and imbibed hospitality for decades. Now, he delves into the advice, opinions, and provocative stories that are helping to define the creative, culturally-necessary space of ‘modern hospitality'—covering topics from front-of-house service, to back-end business operations, and every inch between. “Tales of the Cocktail” - Top 10 Best Broadcast or Podcast (2020). New episodes posted every Tuesday and Friday. Brought to you by www.soolehospitality.com FOLLOW US ON INSTAGRAM – Shawn Soole https://www.instagram.com/shawnsoole/ Soole Hospitality Concepts https://www.instagram.com/soolehospitalityconcepts/ FOLLOW US ON TWITTER - https://twitter.com/ShawnSoole FOLLOW US ON YOUTUBE - https://www.youtube.com/channel/UCGgDDJZM7HvJiQCaqmXEVNA --- Send in a voice message: https://podcasters.spotify.com/pod/show/post-shift/message

Join Sam Clark, our surf reporter as he takes you through a sunny Friday afternoon before Christmas. 

This week, Gilly is at the home of the queen of food writing, the original collector of Middle Eastern and Jewish food and grande dame of food and identity, Claudia Roden.As they celebrate 25 years of Claudia's internationally acclaimed Book of Jewish Food, they discuss the foods in our repertoire now that have been hidden in the kitchens of the Jewish diaspora for centuries - until Claudia wrote them into our world. The influence of the book is a phenomenon; from Alistair Little to Sam and Sam Clark at The Eagle and then at Moro, to Yotam Ottolenghi's 'veg forward' revolution in the early 2000s, Roden's collection of stories and recovered recipes are at the heart of modern British food culture.In this extended Holiday special, she talks about all the things that are good in life – beautiful recipes passed down through matriarchies, storytelling that binds communities and the universal pleasure of food that matters. Hosted on Acast. See acast.com/privacy for more information.

It is always good to catch up with Sam Clark

Sam Clark - JMU Punter by ESPN Harrisonburg

Dedicated to Southern Miss sports! Weekdays 1 - 2 p.m. on select SuperTalk Mississippi stations. This show is a production of SuperTalk Mississippi Media. Learn more at SuperTalk.FM

This week, Gilly is in reflective mood with Sam and Sam Clark, the husband and wife chef team who have given us 25 years of Moorish cooking at Moro to talk about the publication of their latest book, Moro Easy, and the legacy and influence of cook books Sam and Sam are among the most influential chefs in modern British cuisine, bringing delicious, rustic Moorish cooking to Britain back in the 1990s. We met on the morning after the Queen had died, while the media was having a field day discussing who we are at the end of the Elizabethan era. We joined in, and went back to the '90s, to Cool Britannia when Britain was just waking up to how food, like music and fashion was about much more than what we were eating, to discuss who we are now. Hosted on Acast. See acast.com/privacy for more information.

A simple recipe by the duo behind London's Moro and Morito restaurants.

A simple recipe by the duo behind London's Moro and Morito restaurants.See omnystudio.com/listener for privacy information.

Welcome to Episode 72 of The Darlington Podcast!  In this episode, Dean of College Guidance Ivy Brewer talks with new college advisors Jaclyn Haynes, Sam Clark, Toni King and Jared Willerson. College advisors attended conferences and college tours this summer in order to learn more about the field of college guidance and the ever-changing world of college admission. Together with Brewer, they share the most important takeaways they learned at their respective conferences and tours.  https://darlingtonschool.org/Today/Details/6063524 (Click here for complete show notes >>)

Episode 188 is with Ethan Hammerberg of the Chicago White Sox. Ethan is a former teammate of my son in the summers. He was a pitcher at Upper Arlington and played locally at THE Ohio State University. His story of the journey from being dominant, to arm issues, recovery, being rebuilt as a pitcher and being drafted will inspire you. Thank you Ethan for your time and your friendship. Ethan's Bio - (Source) Career Honors Academic All-Big Ten (2021) OSU Scholar-Athlete (2021) 2021 (Sophomore) Appeared in 6 games during his sophomore season Struck out 9 batters across 5.2 total innings of work, finishing with a 6.35 ERA Did not allow an earned run across his last 4 outings of the year against Maryland, Michigan, Purdue and Northwestern, each of which lasted 1 inning. 2020 (Freshman) Made three appearances, posting a 5.40 ERA with seven strikeouts in 3.1 innings pitched Pitched a scoreless inning, striking out the side against Harvard (3/7) Tossed two scoreless innings, fanning four at North Florida (3/10) Prior to Ohio State Three-year letterwinner for Tom Marker and Sam Clark at Upper Arlington High School Played summer ball for Bo Jackson Elite and coach Brandon Belli Personal Son of Chris and Sue Hammerberg Older sister, Kayla, swam at Ohio State A business major --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/aaronconrad/support

Sam Clark joins the show to debrief on the Marlins deadline activity.We also segway into many other topics including Don Mattingly, Avisail Garcia, Stallings legs, Trea Turner. It's a fun one. Enjoy Learn more about your ad choices. Visit podcastchoices.com/adchoices

Sam Clark joins the show to debrief on the Marlins deadline activity. We also segway into many other topics including Don Mattingly, Avisail Garcia, Stallings legs, Trea Turner. It's a fun one. Enjoy Learn more about your ad choices. Visit podcastchoices.com/adchoices

This week, in a special extended episode, Gilly is on stage at the British Library in London whose Food Season has been tantalising food fans with a whole month of talks inspired by the cookbooks, recipes and culinary stories in its collection. Speakers have included Jessica Harris, Angela Hartnett, Dan Saladino, Alice Waters, Felicity Cloake, Frances Moore Lappé and Henry Dimbleby.Gilly's panel of experts explore 13th century Moorish cookery through an extraordinary story of a recently discovered mis-filed manuscript. Come and sit with the sold out audience as Polly Russell, curator of the Food Season introduces Sam and Sam Clark of Moro to the stage with Arabic scholar Nawal Nasrallah and the Curator of Arabic Scientific Manuscripts, Bink Hallum to time travel to Moorish Andalucia and taste 800 year old recipes cooked up Moro-style.To get 10% off the Leith's Essentials online course that Gilly is doing over over the next 6 months, go to leithsonline.com/courses/essential-cooking Click ‘enrol' on course page and apply the code: GILLY10 at checkout: And if you fancy a Free Hollandaise mini-course – sign up for a Workshop account or login at: app.workshop.ws/profile and click ‘Redeem Coupon' on the sidebar. Enter code GILLYSGIFT and click redeem. See acast.com/privacy for privacy and opt-out information.

Sam Clark joins me for an off day EXTRAVAGANZA. Luke Williams now a Marlin... what's the roster move? Pablo, Donnie, Jesus, tons of questions + much more. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Sam Clark joins me for an off day EXTRAVAGANZA. Luke Williams now a Marlin... what's the roster move? Pablo, Donnie, Jesus, tons of questions + much more. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today we hear from Zoo manager Samir Clark as he talks about how he got into the field, his time working with sea lions and his thoughts on marine mammal training. He shares information about what it was like to go from working with sea lions to big cats - namely tigers!

Today on the show, Jessica Hopkins speaks to Victoria Vasyliuk, a resident of Lviv, a city in western Ukraine, around 70 kilometres from the border with Poland, about what it is looking like for refugees fleeing the war.  Charlie Parker talks to Nina Santos, campaign spokesperson for MindTheGap, about their new pay gap registry.  Sam Clark speaks to Unions Auckland Spokesperson Sarah Barker about their endorsement of Manukau Ward Councillor Efeso Collins. Charlie discusses the impact of Long COVID with Dr Anna Brooks from the University of Auckland. Lastly, Charlie interviews Chloe Wollard and Shane Henderson from Auckland City Council about property revaluations and how this will affect the annual budget.

In this episode, guest Sam Clark discusses the traits of white male culture, the significance of diversity in business, and the concept of 'Big Hairy Audacious Goal'. He also explores the role of business development and technology in business growth, the importance of leadership training, and the impact of the White Men's Caucus on diversity.

DIVERSITY should not be a mere trend…It should be part of a way of life – that which promotes individual growth of employees, high quality services leading to TRUE customer satisfaction, and scaling your business.The problem is ever since the executives and business owners caught wind of the term, “Diversity” has been thrown around a lot until it lost its true meaning and value.It's easy create a business that employs people from different background, sex and gender, ethnicity, etc., but is that the end-all and be-all?What most entrepreneurs fail to see is that diversity, on its own, cannot create the huge impact you expect it to have in your KPIs, and ultimately, your business's health.Creating an environment where your diverse work force can thrive is crucial to creating that impact; that environment can be achieved when you build a culture that practices EQUITY and INCLUSION!And that's exactly what Sam Clark had in mind as he led Clark Construction Company to its current state of success!Sam Clark is part of the 3rd generation in his family to manage Clark Construction, and is the current President and CEO of the company.He served in the U. S. Army from 1991 to 1994 and was stationed in Fort Lewis, Washington. Upon his honorable discharge, Sam enrolled in Northern Michigan University where he obtained a B. S. in Building Construction Management.Sam joined Clark Construction Company as a Project Manager in 1996 and has held progressive roles during his rise to President/CEO. During his career, Sam has been involved in many market sectors and is most notably known for his expertise in casino, resort venues.Through developing, implementing, and living our core values, Sam has proven himself as a visionary leader within the organization. The company mission “We Build on a Foundation of Trust” aligns the team in success. Sam has led the organization through significant cultural changes with a strategic focus on Diversity, Equity, and Inclusion (DEI).Today Clark Construction reaps the many benefits of DEI integration.How does DEI impact company KPIs? What other benefits is there when you infuse DEI into the company culture? What other key ideas contributed to Clark Construction's massive growth and current success?Learn more from the source!Reach out to Sam Clark or learn more about Clark Construction Company here:Email: sclark@clarkcc.comWebsite:Clark Construction Company - Professional Construction Management Services Tune in to learn about the Hottest Insider News | Tips | Tricks | Hacks, and everything you need to know on Architecture, Engineering, Construction and Technology!Connect with the Justin & Will:Website: https://spotmigration.com/LinkedIn: https://www.linkedin.com/company/spot-migrationFacebook: https://www.facebook.com/spotmigrationYoutube: http://www.youtube.com/c/SpotmigrationWill's LinkedIn: https://www.linkedin.com/in/willforet/Justin's LinkedIn: https://www.linkedin.com/in/justneagle/Tune in to learn about the Hottest Insider News | Tips | Tricks | Hacks, and everything you need to know on Architecture, Engineering, Construction and Technology!

Aotearoa has the third highest rate of inflammatory bowel disease, or IBD in the world, but essential medication is still unavailable due to Pharmac's budget. Ustekinumab, otherwise known by its brand name – Stelara was approved by MedSafe in 2018 and is already funded in Australia. Crohn's & Colitis NZ petitioned to get Stelara funded here last year - receiving 30,000 signatures. This led to Pharmac testifying before the petitions committee in October last year – where they said Stelara is needed but they still don't have the funding. Sam Clark spoke to the Chair of Crohn's & Colitis NZ, Dr Richard Stein about what has happened since.

Sam Clark speaks to Dr Paul Winton, founder of the 1.5 Project, a foundation that advocates for stronger climate action in Aotearoa. Winton explains what the Climate Change Commission's proposal is missing and how the problem in Aotearoa is the cows and the cars. Winton says we need to treat climate action like we treat Covid-19 - a clear message from central and local government to raise awareness.

2:20 | Emma Jackson on helping to organize the counter-demonstration to the "Freedom" convoy in Edmonton on Saturday (February 12) where she was told by police that she could be charged under Bill 1, the Critical Infrastructure Defence Act. 17:55 | Students Against Kenney organizers, Sam Clark, Toby Maltais, and Lauren Bayne on planning a province-wide school walk out this afternoon, to show their support for mask mandates in schools to keep students and teachers safe. 49:11 | Behavioural scientist Dr. Michelle Drouin on technology, relationships, couples, and sexuality. Her new book is OUT OF TOUCH: How to Survive an Intimacy Famine, is available now. 1:18:31 | #PositiveReflections | Ryan shares about the lighter side of life with an email from a Real Talker. Presented by Kuby Energy.

This is the third episode in which we will be discussing chapters from our new book “Utterly Amazed: Stories from Outside the Boat”. Today, Sam Clark and John discuss their encounter with a man they call Smart Michael in East Asia. This episode is sponsored by: First North and Moss Insurance We will post episodes the 1st and 3rd Tuesdays of each month! Visit our website Email us Instagram Twitter Facebook

Sam Clark is the Co-founder and CEO of Broadway Crew, a street team and staffing agency based out of New York City. Broadway Crew was started in a basement in Brooklyn in 2018, has grown to have more than 200 people on staff with coverage across nearly every major city in United States (with plans to expand abroad in 2022!) In this episode drops his cheat codes on he was able to start a business while not having steady income, get the capital to start your business and what he attributes the fast growth and expansion of the business to.

For our fifth episode, we're talking Moro by Sam and Sam Clark, a chef couple united in their love for Mediterranean and Middle Eastern flavours, simplicity, good ingredients and marrying someone with the same name. We also talk – not related in any way to Moro – about Japan's snack selection, convenience store and a somewhat controversial opinion about French bakeries. Do you have Moro in your cookbook collection? We would love to hear from you @cookbookcircle on Instagram and Twitter! Dive into the very fun world of Japanese convenience store snacks and check out the Conbini Boys on Twitter, @conbiniboysMusic credits:Intro & Outro: Funky Souls – AmariàInterlude: Hot Thang - Daniel Fridell See acast.com/privacy for privacy and opt-out information.

Editor's Note: obituary translated from 21st century English to 29th century English. (1985 - 2899) Kevin Gurburbaby, amateur professional eater ଏବଂ ତିନିଜଣଙ୍କ ପିତା ଗତକାଲି ରାତିରେ ତାଙ୍କ ଘରେ ମୃତ୍ୟୁ ବରଣ କରିଥିଲେ Tempe, Arizona. ସେ ତାଙ୍କ ପତ୍ନୀଙ୍କୁ ଏକ Outback, ସେମାନେ ଏକ Applebees, ସେ ହେଲା food lawyer ଯେତେବେଳେ ସେ ସମସ୍ତ ରୋଜଗାର ଖାଇଲେ - ତାଙ୍କର ଅନେକ ଛୁଟିଦିନ ଏବଂ ଏକାଧିକ ଦ daily ନିକ ଭୋଜନ ଯାତ୍ରା ପାଇଁ ଖର୍ଚ୍ଚ କଲେ. ତାଙ୍କୁ ଅଳ୍ପ ଲୋକ ମନେ ରଖିବେ - ଯେହେତୁ ସେ କେବେବି ରୋଜଗାର କରିନାହାଁନ୍ତି framed picture in a hallway - କିନ୍ତୁ ତାଙ୍କର କଙ୍କାଳଟି ଟେମ୍ପେ ପ୍ରତ୍ନତାତ୍ତ୍ୱିକ ସମାଜ ଦ୍ୱାରା ଆସୁଥିବା ଦଶନ୍ଧି ଧରି ପରୀକ୍ଷା କରାଯିବ. ପାଇଁ ଦାନ କରାଯାଇପାରିବ Arena Football League. This episode is sponsored by: THE ASTROTURF BOTOX & GOLDEN CAROL ft. SAM CLARK - Kevin Gurburbaby TRICIA CRIMMINS - Linda / sponsorships JOHN GOODMAN - Devil / Steven / Steven 2.0 / Law Professor DAN KUAN PEEPLES - God / Kevin 2.0 / Lawyer / Montgomery theme song by Aaron Shapiro an ELEVATOR pod

Well well well, here we are. The good news is Hobbs and Shaw holds up pretty well for being a bastardization of the Fast and Furious franchise. The bad news is - there is no bad news! Enjoy yet another delightful episode where Melindandrew poorly describe intricate  fight scenes and argue over the pronunciation of words. They are also joined by the golden-voiced Sam Clark (@senordavenport) for one last thrill ride. But don't be sad. Stay tuned for a series retrospective and to get more info on what the F8 of this podcast will be...